Vitamin Shoppe Inc. (VSI) CAO Sells $40,228.80 in Stock
Vitamin Shoppe Inc. (NYSE:VSI) CAO Dan Lamadrid sold 1,734 shares of the stock in a transaction dated Tuesday, November 8th. The stock was sold at an average price of $23.20, for a total transaction of $40,228.80. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Vitamin Shoppe Inc. (NYSE:VSI) opened at 25.30 on Monday. The firm has a market cap of $592.80 million, a P/E ratio of 14.92 and a beta of 0.66. The firm has a 50-day moving average of $26.24 and a 200-day moving average of $28.34. Vitamin Shoppe Inc. has a 12-month low of $21.90 and a 12-month high of $34.41.
Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings results on Wednesday, November 2nd. The company reported $0.50 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.50. The business earned $314.90 million during the quarter, compared to analyst estimates of $317.18 million. Vitamin Shoppe had a return on equity of 11.52% and a net margin of 3.34%. The firm’s revenue was up .3% on a year-over-year basis. During the same period in the previous year, the company earned $0.52 EPS. On average, analysts expect that Vitamin Shoppe Inc. will post $2.14 EPS for the current year.
Several brokerages have recently weighed in on VSI. Zacks Investment Research upgraded shares of Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a report on Thursday, October 6th. Morgan Stanley lowered shares of Vitamin Shoppe from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $32.00 to $26.00 in a report on Thursday, November 3rd. Barclays PLC reiterated an “equal weight” rating and set a $29.00 price objective on shares of Vitamin Shoppe in a report on Wednesday, November 2nd. Jefferies Group reiterated a “hold” rating and set a $28.00 price objective on shares of Vitamin Shoppe in a report on Monday, September 26th. Finally, JPMorgan Chase & Co. lowered shares of Vitamin Shoppe from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $33.00 to $28.00 in a report on Thursday, October 27th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. Vitamin Shoppe currently has an average rating of “Hold” and an average target price of $31.46.
Several large investors have recently made changes to their positions in the stock. Weiss Asset Management LP purchased a new stake in shares of Vitamin Shoppe during the third quarter valued at about $237,000. Citadel Advisors LLC raised its stake in shares of Vitamin Shoppe by 20,677.9% in the third quarter. Citadel Advisors LLC now owns 228,557 shares of the company’s stock valued at $6,137,000 after buying an additional 227,457 shares in the last quarter. Morgan Stanley raised its stake in shares of Vitamin Shoppe by 112.8% in the third quarter. Morgan Stanley now owns 155,539 shares of the company’s stock valued at $4,176,000 after buying an additional 82,453 shares in the last quarter. GMT Capital Corp purchased a new stake in shares of Vitamin Shoppe during the third quarter valued at about $7,586,000. Finally, Northern Trust Corp raised its stake in shares of Vitamin Shoppe by 0.9% in the third quarter. Northern Trust Corp now owns 313,988 shares of the company’s stock valued at $8,431,000 after buying an additional 2,786 shares in the last quarter.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.
Receive News & Stock Ratings for Vitamin Shoppe Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc. and related stocks with our FREE daily email newsletter.